中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2014年
9期
88-90
,共3页
支气管哮喘儿童%TH(甲状腺激素)%hs-CRP(高敏C-反应蛋白)%治疗%分析
支氣管哮喘兒童%TH(甲狀腺激素)%hs-CRP(高敏C-反應蛋白)%治療%分析
지기관효천인동%TH(갑상선격소)%hs-CRP(고민C-반응단백)%치료%분석
bronchial asthma thyroid hormone%(TH ) high sensitive c-reactive protein%( hs-CRP) therapy%analysis
目的:探讨支气管哮喘患儿治疗前后血清甲状腺激素(TH)和高敏C-反应蛋白(hs-CRP)水平的临床分析。方法155例支气管哮喘患儿和56例正常儿对照组血清TH和hs-CRP水平通过化学发光免疫分析和免疫荧光干式定量法测定并进行了比较性分析。结果治疗前支气管哮喘患儿血清T3、T4和FT3水平较对照组降低(P<0.05),FT4水平差异无统计学意义(P>0.05),TSH水平增高(P<0.01);其中轻中哮喘组T3、T4和FT3较正常儿降低(P<0.05), F T4无明显差异(P>0.05),T S H水平增高(P<0.05);重度哮喘组T3、T4和F T3水平较正常儿明显降低(P分别为<0.001、<0.05和<0.001),血清F T4无明显差异(P>0.05),T S H增高(P<0.01)。糖皮质激素治疗后,轻中哮喘患儿T H恢复正常(P >0.05);重度哮喘组T3和F T3有所增高,但较之正常儿仍有差异(P<0.05),T4、FT4和TSH恢复正常(P >0.05)。治疗前,支气管哮喘患儿血清hs-CRP水平较正常儿增高(P<0.01);治疗后轻中哮喘组恢复正常(P>0.05),重度哮喘组治疗后好转,但仍有差异(P<0.05)。结论 T3和 FT3水平随支气管哮喘患儿的疾病严重程度而降低,血清TSH和hs-CRP水平随疾病严重程度增高。
目的:探討支氣管哮喘患兒治療前後血清甲狀腺激素(TH)和高敏C-反應蛋白(hs-CRP)水平的臨床分析。方法155例支氣管哮喘患兒和56例正常兒對照組血清TH和hs-CRP水平通過化學髮光免疫分析和免疫熒光榦式定量法測定併進行瞭比較性分析。結果治療前支氣管哮喘患兒血清T3、T4和FT3水平較對照組降低(P<0.05),FT4水平差異無統計學意義(P>0.05),TSH水平增高(P<0.01);其中輕中哮喘組T3、T4和FT3較正常兒降低(P<0.05), F T4無明顯差異(P>0.05),T S H水平增高(P<0.05);重度哮喘組T3、T4和F T3水平較正常兒明顯降低(P分彆為<0.001、<0.05和<0.001),血清F T4無明顯差異(P>0.05),T S H增高(P<0.01)。糖皮質激素治療後,輕中哮喘患兒T H恢複正常(P >0.05);重度哮喘組T3和F T3有所增高,但較之正常兒仍有差異(P<0.05),T4、FT4和TSH恢複正常(P >0.05)。治療前,支氣管哮喘患兒血清hs-CRP水平較正常兒增高(P<0.01);治療後輕中哮喘組恢複正常(P>0.05),重度哮喘組治療後好轉,但仍有差異(P<0.05)。結論 T3和 FT3水平隨支氣管哮喘患兒的疾病嚴重程度而降低,血清TSH和hs-CRP水平隨疾病嚴重程度增高。
목적:탐토지기관효천환인치료전후혈청갑상선격소(TH)화고민C-반응단백(hs-CRP)수평적림상분석。방법155례지기관효천환인화56례정상인대조조혈청TH화hs-CRP수평통과화학발광면역분석화면역형광간식정량법측정병진행료비교성분석。결과치료전지기관효천환인혈청T3、T4화FT3수평교대조조강저(P<0.05),FT4수평차이무통계학의의(P>0.05),TSH수평증고(P<0.01);기중경중효천조T3、T4화FT3교정상인강저(P<0.05), F T4무명현차이(P>0.05),T S H수평증고(P<0.05);중도효천조T3、T4화F T3수평교정상인명현강저(P분별위<0.001、<0.05화<0.001),혈청F T4무명현차이(P>0.05),T S H증고(P<0.01)。당피질격소치료후,경중효천환인T H회복정상(P >0.05);중도효천조T3화F T3유소증고,단교지정상인잉유차이(P<0.05),T4、FT4화TSH회복정상(P >0.05)。치료전,지기관효천환인혈청hs-CRP수평교정상인증고(P<0.01);치료후경중효천조회복정상(P>0.05),중도효천조치료후호전,단잉유차이(P<0.05)。결론 T3화 FT3수평수지기관효천환인적질병엄중정도이강저,혈청TSH화hs-CRP수평수질병엄중정도증고。
Objective To explore clinical analysis of serum thyroid hormone (TH ) and high sensitive c-reactive protein(hs-CRP)levels in before and after therapy in patients with bronchial asthma . Methods The TH and hs-CRP levels were determined in 155 patients with bronchial asthma ( including 73 cases mild bronchial asthma and 82 cases severe bronchial asthma ) and 56 controls by chemoluminescence immuno assay and immuno flurorescent dry quantity methods as wel as done study compared. Results In before therapy , the serum T3、T4 and FT3 levels in 155 patients with bronchial asthma were significantly lower than in those of 56 controls (P <0.01、<0.05 and <0.01 , respectively ) 、the serum FT4 was no significantly different (P>0.05) and the serum TSH levels was increased (P<0.05). The serum T3、T4 and FT3 levels in 73 patients with mild bronchial asthma were lower than in those of 56 controls ( P al <0.05 ) , the serum FT4 level was no significantly different (P>0.05) and the serum TSH level was increased (P<0.05). But the serum T3、T4 and FT3 levels in 82 patients with severe bronchial asthma were very significantly lower than in those of 56 controls (P <0.001、<0.05 and <0.001 , respectively) , the serum FT4 levels was no significantly different (P>0.05) and the serum TSH level was significantly higher (P<0.01). The serum T3 and FT3 levels were decreased and the serum TSH levels was increased with bronchial asthma severity . After inhalation of glucocorticoids therapy , the serum TH levels in 73 patients with mild bronchial asthma return to normal ( P al >0.05 ) . The serum T3 and FT3 levels in 82 patients with severe bronchial asthma were significantly higher but stil were lower than in those of 56 controls ( P al <0.05 ) , the serum T4、FT4 and TSH level were normal ( P al >0.05 ) . In Before therapy , the serum hs-CRP level in 155 patients with bronchial asthma was significantly higher than in those of 56 controls (P<0.01). The serum hs-CRP levels in 73 patients with mild bronchial asthma was increased (P<0.05), and return to normal after therapy . The serum hs-CRP level in 82 patients with severe was significantly increased , and stil increased after therapy .